Malignant carcinoid: effect of parenteral methotrexate (NSC-740) therapy alone and in combination with cyclophosphamide (NSC-26271) orally.
作者信息
Mengel C E
出版信息
Cancer Chemother Rep. 1967 Aug;51(4):239-44.
PMID:5623734
Abstract
摘要
相似文献
1
2
Effect of melphalan in the malignant carcinoid syndrome.美法仑对恶性类癌综合征的作用。
Arch Intern Med. 1969 Jul;124(1):36-8.
3
Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Cancer Treat Rep. 1984 Apr;68(4):665-7.
4
Response of metastatic malignant carcinoid tumor to adriamycin (NSC-123127).转移性恶性类癌肿瘤对阿霉素（NSC-123127）的反应。
Cancer Treat Rep. 1976 Mar;60(3):273-6.
5
Diagnosis and treatment of malignant carcinoid syndrome.恶性类癌综合征的诊断与治疗。
JAMA. 1974 Sep 2;229(10):1346-8.
6
Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Cancer Treat Rep. 1976 May;60(5):527-33.
7
Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):943-5.
8
Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
J Med Assoc Thai. 1978 Mar;61(3):158-61.
9
Abdominal crisis in the malignant carcinoid syndrome.恶性类癌综合征中的腹部危象
Arch Intern Med. 1966 Feb;117(2):256-60.
10
Hepatic artery ligation in treatment of carcinoid syndrome.肝动脉结扎术治疗类癌综合征。
Can Med Assoc J. 1975 Feb 8;112(3):325-7.
引用本文的文献
1
Chemotherapy for the carcinoid syndrome.类癌综合征的化疗
Cancer Chemother Pharmacol. 1981;5(3):133-8. doi: 10.1007/BF00258469.
Zotero 插件